0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Infectious Disease Testing - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Othe-4U222
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Testing Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Infectious Disease Testing - Global Market Insights and Sales Trends 2024

Code: QYRE-Othe-4U222
Report
December 2023
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infectious Disease Testing - Market Size

The global Infectious Disease Testing market size is expected to reach US$ 21090 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029.

Infectious Disease Testing -  Market

Infectious Disease Testing - Market

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
The market is mainly driven by the significant applications of Infectious Disease Testing in various end use industries. The expanding demands from the Hospitals/Clinical Laboratories, Reference Laboratories, Academic/Research Institutes and Other, are propelling Infectious Disease Testing market. Immunodiagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clinical Microbiology segment is estimated at % CAGR for the next seven-year period.
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.

Report Objectives

This report provides market insight on the different segments, by players, by Technology, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Infectious Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infectious Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infectious Disease Testing covered in this report include Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq and BD, etc.
The global Infectious Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical

Scope of Infectious Disease Testing - Market Report

Report Metric Details
Report Name Infectious Disease Testing - Market
Forecasted market size in 2029 US$ 21090 million
CAGR 3.5%
Forecasted years 2023 - 2029
Global Infectious Disease Testing market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Disease Testing market, Segment by Technology:
  • Immunodiagnostics
  • Clinical Microbiology
  • PCR
  • INAAT
  • DNA Sequencing & NGS
  • DNA Microarrays
  • Other
Global Infectious Disease Testing market, by Application
  • Hospitals/Clinical Laboratories
  • Reference Laboratories
  • Academic/Research Institutes
  • Other
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Infectious Disease Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Infectious Disease Testing - Market size in 2029?

Ans: The Infectious Disease Testing - Market size in 2029 will be US$ 21090 million.

What are the Application segmentation covered in the Infectious Disease Testing - Market report?

Ans: The Applications covered in the Infectious Disease Testing - Market report are Hospitals/Clinical Laboratories, Reference Laboratories, Academic/Research Institutes, Other

1 Market Overview of Infectious Disease Testing
1.1 Infectious Disease Testing Market Overview
1.1.1 Infectious Disease Testing Product Scope
1.1.2 Infectious Disease Testing Market Status and Outlook
1.2 Global Infectious Disease Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infectious Disease Testing Market Size by Region (2018-2029)
1.4 Global Infectious Disease Testing Historic Market Size by Region (2018-2023)
1.5 Global Infectious Disease Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infectious Disease Testing Market Size (2018-2029)
1.6.1 North America Infectious Disease Testing Market Size (2018-2029)
1.6.2 Europe Infectious Disease Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Infectious Disease Testing Market Size (2018-2029)
1.6.4 Latin America Infectious Disease Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Infectious Disease Testing Market Size (2018-2029)
2 Infectious Disease Testing Market by Technology
2.1 Introduction
2.1.1 Immunodiagnostics
2.1.2 Clinical Microbiology
2.1.3 PCR
2.1.4 INAAT
2.1.5 DNA Sequencing & NGS
2.1.6 DNA Microarrays
2.1.7 Other
2.2 Global Infectious Disease Testing Market Size by Technology: 2018 VS 2022 VS 2029
2.2.1 Global Infectious Disease Testing Historic Market Size by Technology (2018-2023)
2.2.2 Global Infectious Disease Testing Forecasted Market Size by Technology (2024-2029)
2.3 Key Regions Market Size by Technology
2.3.1 North America Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
2.3.2 Europe Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
2.3.3 Asia-Pacific Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
2.3.4 Latin America Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
2.3.5 Middle East and Africa Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
3 Infectious Disease Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals/Clinical Laboratories
3.1.2 Reference Laboratories
3.1.3 Academic/Research Institutes
3.1.4 Other
3.2 Global Infectious Disease Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infectious Disease Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Infectious Disease Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
4 Infectious Disease Testing Competition Analysis by Players
4.1 Global Infectious Disease Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2022)
4.3 Date of Key Players Enter into Infectious Disease Testing Market
4.4 Global Top Players Infectious Disease Testing Headquarters and Area Served
4.5 Key Players Infectious Disease Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Infectious Disease Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Diagnostics
5.1.1 Abbott Diagnostics Profile
5.1.2 Abbott Diagnostics Main Business
5.1.3 Abbott Diagnostics Infectious Disease Testing Products, Services and Solutions
5.1.4 Abbott Diagnostics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Diagnostics Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Infectious Disease Testing Products, Services and Solutions
5.2.4 Abbott Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Beckman Coulter Diagnostics
5.3.1 Beckman Coulter Diagnostics Profile
5.3.2 Beckman Coulter Diagnostics Main Business
5.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Products, Services and Solutions
5.3.4 Beckman Coulter Diagnostics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Infectious Disease Testing Products, Services and Solutions
5.4.4 Roche Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Siemens Healthcare
5.5.1 Siemens Healthcare Profile
5.5.2 Siemens Healthcare Main Business
5.5.3 Siemens Healthcare Infectious Disease Testing Products, Services and Solutions
5.5.4 Siemens Healthcare Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Siemens Healthcare Recent Developments
5.6 Abaxis
5.6.1 Abaxis Profile
5.6.2 Abaxis Main Business
5.6.3 Abaxis Infectious Disease Testing Products, Services and Solutions
5.6.4 Abaxis Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Abaxis Recent Developments
5.7 Acon Laboratories
5.7.1 Acon Laboratories Profile
5.7.2 Acon Laboratories Main Business
5.7.3 Acon Laboratories Infectious Disease Testing Products, Services and Solutions
5.7.4 Acon Laboratories Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Acon Laboratories Recent Developments
5.8 Avioq
5.8.1 Avioq Profile
5.8.2 Avioq Main Business
5.8.3 Avioq Infectious Disease Testing Products, Services and Solutions
5.8.4 Avioq Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Avioq Recent Developments
5.9 BD
5.9.1 BD Profile
5.9.2 BD Main Business
5.9.3 BD Infectious Disease Testing Products, Services and Solutions
5.9.4 BD Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.9.5 BD Recent Developments
5.10 Bio-Rad Laboratories
5.10.1 Bio-Rad Laboratories Profile
5.10.2 Bio-Rad Laboratories Main Business
5.10.3 Bio-Rad Laboratories Infectious Disease Testing Products, Services and Solutions
5.10.4 Bio-Rad Laboratories Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Laboratories Recent Developments
5.11 Cavidi
5.11.1 Cavidi Profile
5.11.2 Cavidi Main Business
5.11.3 Cavidi Infectious Disease Testing Products, Services and Solutions
5.11.4 Cavidi Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Cavidi Recent Developments
5.12 Cepheid
5.12.1 Cepheid Profile
5.12.2 Cepheid Main Business
5.12.3 Cepheid Infectious Disease Testing Products, Services and Solutions
5.12.4 Cepheid Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Cepheid Recent Developments
5.13 Chembio Diagnostic Systems
5.13.1 Chembio Diagnostic Systems Profile
5.13.2 Chembio Diagnostic Systems Main Business
5.13.3 Chembio Diagnostic Systems Infectious Disease Testing Products, Services and Solutions
5.13.4 Chembio Diagnostic Systems Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Chembio Diagnostic Systems Recent Developments
5.14 Clarity Diagnostics
5.14.1 Clarity Diagnostics Profile
5.14.2 Clarity Diagnostics Main Business
5.14.3 Clarity Diagnostics Infectious Disease Testing Products, Services and Solutions
5.14.4 Clarity Diagnostics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Clarity Diagnostics Recent Developments
5.15 EMD Millipore
5.15.1 EMD Millipore Profile
5.15.2 EMD Millipore Main Business
5.15.3 EMD Millipore Infectious Disease Testing Products, Services and Solutions
5.15.4 EMD Millipore Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.15.5 EMD Millipore Recent Developments
5.16 Epitope Diagnostic
5.16.1 Epitope Diagnostic Profile
5.16.2 Epitope Diagnostic Main Business
5.16.3 Epitope Diagnostic Infectious Disease Testing Products, Services and Solutions
5.16.4 Epitope Diagnostic Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Epitope Diagnostic Recent Developments
5.17 Gold Standard Diagnostics
5.17.1 Gold Standard Diagnostics Profile
5.17.2 Gold Standard Diagnostics Main Business
5.17.3 Gold Standard Diagnostics Infectious Disease Testing Products, Services and Solutions
5.17.4 Gold Standard Diagnostics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Gold Standard Diagnostics Recent Developments
5.18 Hologic
5.18.1 Hologic Profile
5.18.2 Hologic Main Business
5.18.3 Hologic Infectious Disease Testing Products, Services and Solutions
5.18.4 Hologic Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.18.5 Hologic Recent Developments
5.19 Immunetics
5.19.1 Immunetics Profile
5.19.2 Immunetics Main Business
5.19.3 Immunetics Infectious Disease Testing Products, Services and Solutions
5.19.4 Immunetics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.19.5 Immunetics Recent Developments
5.20 InBios International
5.20.1 InBios International Profile
5.20.2 InBios International Main Business
5.20.3 InBios International Infectious Disease Testing Products, Services and Solutions
5.20.4 InBios International Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.20.5 InBios International Recent Developments
5.21 Life Technologies
5.21.1 Life Technologies Profile
5.21.2 Life Technologies Main Business
5.21.3 Life Technologies Infectious Disease Testing Products, Services and Solutions
5.21.4 Life Technologies Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.21.5 Life Technologies Recent Developments
5.22 Maxim Biomedical
5.22.1 Maxim Biomedical Profile
5.22.2 Maxim Biomedical Main Business
5.22.3 Maxim Biomedical Infectious Disease Testing Products, Services and Solutions
5.22.4 Maxim Biomedical Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.22.5 Maxim Biomedical Recent Developments
6 North America
6.1 North America Infectious Disease Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infectious Disease Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infectious Disease Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infectious Disease Testing Market Dynamics
11.1 Infectious Disease Testing Industry Trends
11.2 Infectious Disease Testing Market Drivers
11.3 Infectious Disease Testing Market Challenges
11.4 Infectious Disease Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Infectious Disease Testing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Infectious Disease Testing Market Size Share by Region (2018-2023)
    Table 4. Global Infectious Disease Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Infectious Disease Testing Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Infectious Disease Testing Market Size (US$ Million) by Technology: 2018 VS 2022 VS 2029
    Table 7. Global Infectious Disease Testing Market Size by Technology (2018-2023) & (US$ Million)
    Table 8. Global Infectious Disease Testing Revenue Market Share by Technology (2018-2023)
    Table 9. Global Infectious Disease Testing Forecasted Market Size by Technology (2024-2029) & (US$ Million)
    Table 10. Global Infectious Disease Testing Revenue Market Share by Technology (2024-2029)
    Table 11. North America Infectious Disease Testing Revenue by Technology (2018-2023) & (US$ Million)
    Table 12. North America Infectious Disease Testing Revenue by Technology (2024-2029) & (US$ Million)
    Table 13. Europe Infectious Disease Testing Revenue by Technology (2018-2023) & (US$ Million)
    Table 14. Europe Infectious Disease Testing Revenue by Technology (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Infectious Disease Testing Revenue by Technology (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Infectious Disease Testing Revenue by Technology (2024-2029) & (US$ Million)
    Table 17. Latin America Infectious Disease Testing Revenue by Technology (2018-2023) & (US$ Million)
    Table 18. Latin America Infectious Disease Testing Revenue by Technology (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Infectious Disease Testing Revenue by Technology (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Infectious Disease Testing Revenue by Technology (2024-2029) & (US$ Million)
    Table 21. Global Infectious Disease Testing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Infectious Disease Testing Revenue Market Share by Application (2018-2023)
    Table 24. Global Infectious Disease Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Infectious Disease Testing Revenue Market Share by Application (2024-2029)
    Table 26. North America Infectious Disease Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Infectious Disease Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Infectious Disease Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Infectious Disease Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Infectious Disease Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Infectious Disease Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Infectious Disease Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Infectious Disease Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Infectious Disease Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Infectious Disease Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Infectious Disease Testing Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Infectious Disease Testing Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2022)
    Table 39. Date of Key Players Enter into Infectious Disease Testing Market
    Table 40. Global Infectious Disease Testing Key Players Headquarters and Area Served
    Table 41. Infectious Disease Testing Product Solution and Service
    Table 42. Global Infectious Disease Testing Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Abbott Diagnostics Basic Information List
    Table 45. Abbott Diagnostics Description and Business Overview
    Table 46. Abbott Diagnostics Infectious Disease Testing Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Infectious Disease Testing Business of Abbott Diagnostics (2018-2023)
    Table 48. Abbott Diagnostics Recent Developments
    Table 49. Abbott Basic Information List
    Table 50. Abbott Description and Business Overview
    Table 51. Abbott Infectious Disease Testing Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Infectious Disease Testing Business of Abbott (2018-2023)
    Table 53. Abbott Recent Developments
    Table 54. Beckman Coulter Diagnostics Basic Information List
    Table 55. Beckman Coulter Diagnostics Description and Business Overview
    Table 56. Beckman Coulter Diagnostics Infectious Disease Testing Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Infectious Disease Testing Business of Beckman Coulter Diagnostics (2018-2023)
    Table 58. Beckman Coulter Diagnostics Recent Developments
    Table 59. Roche Basic Information List
    Table 60. Roche Description and Business Overview
    Table 61. Roche Infectious Disease Testing Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Infectious Disease Testing Business of Roche (2018-2023)
    Table 63. Roche Recent Developments
    Table 64. Siemens Healthcare Basic Information List
    Table 65. Siemens Healthcare Description and Business Overview
    Table 66. Siemens Healthcare Infectious Disease Testing Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Infectious Disease Testing Business of Siemens Healthcare (2018-2023)
    Table 68. Siemens Healthcare Recent Developments
    Table 69. Abaxis Basic Information List
    Table 70. Abaxis Description and Business Overview
    Table 71. Abaxis Infectious Disease Testing Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Infectious Disease Testing Business of Abaxis (2018-2023)
    Table 73. Abaxis Recent Developments
    Table 74. Acon Laboratories Basic Information List
    Table 75. Acon Laboratories Description and Business Overview
    Table 76. Acon Laboratories Infectious Disease Testing Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Infectious Disease Testing Business of Acon Laboratories (2018-2023)
    Table 78. Acon Laboratories Recent Developments
    Table 79. Avioq Basic Information List
    Table 80. Avioq Description and Business Overview
    Table 81. Avioq Infectious Disease Testing Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Infectious Disease Testing Business of Avioq (2018-2023)
    Table 83. Avioq Recent Developments
    Table 84. BD Basic Information List
    Table 85. BD Description and Business Overview
    Table 86. BD Infectious Disease Testing Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Infectious Disease Testing Business of BD (2018-2023)
    Table 88. BD Recent Developments
    Table 89. Bio-Rad Laboratories Basic Information List
    Table 90. Bio-Rad Laboratories Description and Business Overview
    Table 91. Bio-Rad Laboratories Infectious Disease Testing Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Infectious Disease Testing Business of Bio-Rad Laboratories (2018-2023)
    Table 93. Bio-Rad Laboratories Recent Developments
    Table 94. Cavidi Basic Information List
    Table 95. Cavidi Description and Business Overview
    Table 96. Cavidi Infectious Disease Testing Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Infectious Disease Testing Business of Cavidi (2018-2023)
    Table 98. Cavidi Recent Developments
    Table 99. Cepheid Basic Information List
    Table 100. Cepheid Description and Business Overview
    Table 101. Cepheid Infectious Disease Testing Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Infectious Disease Testing Business of Cepheid (2018-2023)
    Table 103. Cepheid Recent Developments
    Table 104. Chembio Diagnostic Systems Basic Information List
    Table 105. Chembio Diagnostic Systems Description and Business Overview
    Table 106. Chembio Diagnostic Systems Infectious Disease Testing Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Infectious Disease Testing Business of Chembio Diagnostic Systems (2018-2023)
    Table 108. Chembio Diagnostic Systems Recent Developments
    Table 109. Clarity Diagnostics Basic Information List
    Table 110. Clarity Diagnostics Description and Business Overview
    Table 111. Clarity Diagnostics Infectious Disease Testing Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Infectious Disease Testing Business of Clarity Diagnostics (2018-2023)
    Table 113. Clarity Diagnostics Recent Developments
    Table 114. EMD Millipore Basic Information List
    Table 115. EMD Millipore Description and Business Overview
    Table 116. EMD Millipore Infectious Disease Testing Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Infectious Disease Testing Business of EMD Millipore (2018-2023)
    Table 118. EMD Millipore Recent Developments
    Table 119. Epitope Diagnostic Basic Information List
    Table 120. Epitope Diagnostic Description and Business Overview
    Table 121. Epitope Diagnostic Infectious Disease Testing Products, Services and Solutions
    Table 122. Revenue (US$ Million) in Infectious Disease Testing Business of Epitope Diagnostic (2018-2023)
    Table 123. Epitope Diagnostic Recent Developments
    Table 124. Gold Standard Diagnostics Basic Information List
    Table 125. Gold Standard Diagnostics Description and Business Overview
    Table 126. Gold Standard Diagnostics Infectious Disease Testing Products, Services and Solutions
    Table 127. Revenue (US$ Million) in Infectious Disease Testing Business of Gold Standard Diagnostics (2018-2023)
    Table 128. Gold Standard Diagnostics Recent Developments
    Table 129. Hologic Basic Information List
    Table 130. Hologic Description and Business Overview
    Table 131. Hologic Infectious Disease Testing Products, Services and Solutions
    Table 132. Revenue (US$ Million) in Infectious Disease Testing Business of Hologic (2018-2023)
    Table 133. Hologic Recent Developments
    Table 134. Immunetics Basic Information List
    Table 135. Immunetics Description and Business Overview
    Table 136. Immunetics Infectious Disease Testing Products, Services and Solutions
    Table 137. Revenue (US$ Million) in Infectious Disease Testing Business of Immunetics (2018-2023)
    Table 138. Immunetics Recent Developments
    Table 139. InBios International Basic Information List
    Table 140. InBios International Description and Business Overview
    Table 141. InBios International Infectious Disease Testing Products, Services and Solutions
    Table 142. Revenue (US$ Million) in Infectious Disease Testing Business of InBios International (2018-2023)
    Table 143. InBios International Recent Developments
    Table 144. Life Technologies Basic Information List
    Table 145. Life Technologies Description and Business Overview
    Table 146. Life Technologies Infectious Disease Testing Products, Services and Solutions
    Table 147. Revenue (US$ Million) in Infectious Disease Testing Business of Life Technologies (2018-2023)
    Table 148. Life Technologies Recent Developments
    Table 149. Maxim Biomedical Basic Information List
    Table 150. Maxim Biomedical Description and Business Overview
    Table 151. Maxim Biomedical Infectious Disease Testing Products, Services and Solutions
    Table 152. Revenue (US$ Million) in Infectious Disease Testing Business of Maxim Biomedical (2018-2023)
    Table 153. Maxim Biomedical Recent Developments
    Table 154. North America Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 155. North America Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 156. Europe Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 157. Europe Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 158. Asia-Pacific Infectious Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 159. Asia-Pacific Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 160. Asia-Pacific Infectious Disease Testing Market Size by Region (2024-2029) & (US$ Million)
    Table 161. Asia-Pacific Infectious Disease Testing Market Share by Region (2018-2023)
    Table 162. Asia-Pacific Infectious Disease Testing Market Share by Region (2024-2029)
    Table 163. Latin America Infectious Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 164. Latin America Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 165. Latin America Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 166. Middle East & Africa Infectious Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 167. Middle East & Africa Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 168. Middle East & Africa Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 169. Infectious Disease Testing Market Trends
    Table 170. Infectious Disease Testing Market Drivers
    Table 171. Infectious Disease Testing Market Challenges
    Table 172. Infectious Disease Testing Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Disease Testing Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Infectious Disease Testing Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Infectious Disease Testing Market Share by Regions: 2022 VS 2029
    Figure 4. Global Infectious Disease Testing Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Infectious Disease Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Infectious Disease Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Infectious Disease Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Infectious Disease Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Infectious Disease Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Immunodiagnostics
    Figure 11. Global Immunodiagnostics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Clinical Microbiology
    Figure 13. Global Clinical Microbiology Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of PCR
    Figure 15. Global PCR Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of INAAT
    Figure 17. Global INAAT Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Product Picture of DNA Sequencing & NGS
    Figure 19. Global DNA Sequencing & NGS Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 20. Product Picture of DNA Microarrays
    Figure 21. Global DNA Microarrays Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Product Picture of Other
    Figure 23. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Global Infectious Disease Testing Market Size Share by Technology: 2022 & 2029
    Figure 25. North America Infectious Disease Testing Revenue Market Share by Technology (2018-2029)
    Figure 26. Europe Infectious Disease Testing Revenue Market Share by Technology (2018-2029)
    Figure 27. Asia-Pacific Infectious Disease Testing Revenue Market Share by Technology (2018-2029)
    Figure 28. Latin America Infectious Disease Testing Revenue Market Share by Technology (2018-2029)
    Figure 29. Middle East and Africa Infectious Disease Testing Revenue Market Share by Technology (2018-2029)
    Figure 30. Hospitals/Clinical Laboratories Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 31. Reference Laboratories Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 32. Academic/Research Institutes Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 33. Other Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 34. Global Infectious Disease Testing Market Size Share by Application: 2022 & 2029
    Figure 35. North America Infectious Disease Testing Revenue Market Share by Application (2018-2029)
    Figure 36. Europe Infectious Disease Testing Revenue Market Share by Application (2018-2029)
    Figure 37. Asia-Pacific Infectious Disease Testing Revenue Market Share by Application (2018-2029)
    Figure 38. Latin America Infectious Disease Testing Revenue Market Share by Application (2018-2029)
    Figure 39. Middle East and Africa Infectious Disease Testing Revenue Market Share by Application (2018-2029)
    Figure 40. Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 41. Global Top 5 and Top 10 Players Infectious Disease Testing Market Share in 2022
    Figure 42. North America Infectious Disease Testing Market Share by Country (2018-2029)
    Figure 43. U.S. Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 44. Canada Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 45. Germany Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 46. France Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 47. U.K. Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 48. Italy Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 49. Russia Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 50. Nordic Countries Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 51. Asia-Pacific Infectious Disease Testing Market Share by Region (2018-2029)
    Figure 52. China Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 53. Japan Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 54. South Korea Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 55. Southeast Asia Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 56. India Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 57. Australia Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 58. Latin America Infectious Disease Testing Market Share by Country (2018-2029)
    Figure 59. Mexico Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 60. Brazil Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 61. Middle East & Africa Infectious Disease Testing Market Share by Country (2018-2029)
    Figure 62. Turkey Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 63. Saudi Arabia Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 64. UAE Infectious Disease Testing Market Size (2018-2029) & (US$ Million)
    Figure 65. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String